These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3827933)

  • 1. Measurements of in vivo hepatic halothane metabolism in rats using 19F NMR spectroscopy.
    Selinsky BS; Thompson M; London RE
    Biochem Pharmacol; 1987 Feb; 36(4):413-6. PubMed ID: 3827933
    [No Abstract]   [Full Text] [Related]  

  • 2. Reductive metabolism of halothane by cytochrome P450 isoforms in rats and humans.
    Chow T; Imaoka S; Hiroi T; Funae Y
    Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):363-74. PubMed ID: 8896047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of halothane distribution in the rat head using 19F NMR technique.
    Wyrwicz AM; Conboy CB
    Magn Reson Med; 1989 Feb; 9(2):219-28. PubMed ID: 2716506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of isoniazid, phenobarbital, phenytoin, pregnenolone 16-alpha carbonitrile, and beta-naphthoflavone on halothane metabolism and hepatotoxicity.
    Jenner MA; Plummer JL; Cousins MJ
    Drug Metab Dispos; 1990; 18(5):819-22. PubMed ID: 1981743
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxygen concentrations required for reductive defluorination of halothane by rat hepatic microsomes.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR; Waters SJ
    Anesth Analg; 1986 Aug; 65(8):835-9. PubMed ID: 3729018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo 19F-NMR study of halothane distribution in brain.
    Wyrwicz AM; Conboy CB; Nichols BG; Ryback KR; Eisele P
    Biochim Biophys Acta; 1987 Jul; 929(3):271-7. PubMed ID: 3607085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical evidence of trifluoroacetylated cytochrome P-450 in the liver of halothane-treated rats.
    Satoh H; Gillette JR; Davies HW; Schulick RD; Pohl LR
    Mol Pharmacol; 1985 Nov; 28(5):468-74. PubMed ID: 3903473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halothane metabolism. Impairment of hepatic omega-oxidation of leukotrienes in vivo and in vitro.
    Huwyler J; Jedlitschky G; Keppler D; Gut J
    Eur J Biochem; 1992 Jun; 206(3):869-79. PubMed ID: 1318837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo 19F NMR imaging.
    McFarland E; Koutcher JA; Rosen BR; Teicher B; Brady TJ
    J Comput Assist Tomogr; 1985; 9(1):8-15. PubMed ID: 3968284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halothane hepatotoxicity and reductive metabolism of halothane in acute experimental liver injury in rats.
    Nomura F; Hatano H; Iida S; Ohnishi K
    Anesth Analg; 1988 May; 67(5):448-52. PubMed ID: 3364763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo study of halothane uptake and elimination in the rat brain with fluorine nuclear magnetic resonance spectroscopy.
    Litt L; González-Méndez R; James TL; Sessler DI; Mills P; Chew W; Moseley M; Pereira B; Severinghaus JW; Hamilton WK
    Anesthesiology; 1987 Aug; 67(2):161-8. PubMed ID: 3605742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity.
    Cousins MJ; Sharp JH; Gourlay GK; Adams JF; Haynes WD; Whitehead R
    Anaesth Intensive Care; 1979 Feb; 7(1):9-24. PubMed ID: 434454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oxygen concentration on the reaction of halothane with cytochrome P450 in liver microsomes and isolated perfused rat liver.
    Nastainczyk W; Ullrich V
    Biochem Pharmacol; 1978 Feb; 27(4):387-92. PubMed ID: 629799
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulatory effects of halothane and isoflurane on fluoride release and cytochrome P-450 loss caused by metabolism of 2-chloro-1,1-difluoroethene, a halothane metabolite.
    Baker MT; Bates JN; Leff SV
    Anesth Analg; 1987 Nov; 66(11):1141-7. PubMed ID: 2889401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the stability and cytochrome P450 specificity of the phenobarbital-induced reductive halothane-cytochrome P450 complex formed in rat hepatic microsomes.
    Baker MT; Vasquez MT; Chiang CK
    Biochem Pharmacol; 1991 Jun; 41(11):1691-9. PubMed ID: 2043158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The release of inorganic fluoride from halothane and halothane metabolites by cytochrome P-450, hemin, and hemoglobin.
    Baker MT; Nelson RM; Van Dyke RA
    Drug Metab Dispos; 1983; 11(4):308-11. PubMed ID: 6137335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of reductive dehalogenation of halothane by liver cytochrome P450.
    Ahr HJ; King LJ; Nastainczyk W; Ullrich V
    Biochem Pharmacol; 1982 Feb; 31(3):383-90. PubMed ID: 7073765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme induction in liver, kidney and lung after inhalation of halothane and enflurane.
    Dale O; Nielsen K; Nilsen OG
    Dev Toxicol Environ Sci; 1983; 11():407-10. PubMed ID: 6428854
    [No Abstract]   [Full Text] [Related]  

  • 19. Sex differences in halothane metabolism and hepatotoxicity in a rat model.
    Plummer JL; Hall PM; Jenner MA; Cousins MJ
    Anesth Analg; 1985 Jun; 64(6):563-9. PubMed ID: 4003773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cimetidine on anesthetic metabolism and toxicity.
    Wood M; Uetrecht J; Phythyon JM; Shay S; Sweetman BJ; Shaheen O; Wood AJ
    Anesth Analg; 1986 May; 65(5):481-8. PubMed ID: 3963434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.